Set and Setting: The Most Important Variables in a Psychedelic Experience

What set and setting mean

"Set" is the mindset a person brings to a psychedelic experience: their expectations, mood and intentions. "Setting" is the physical, social and cultural environment it happens in. (Journal of Psychopharmacology, 2023) Researchers use the pair to explain why the same drug at the same dose can produce very different experiences in different people and places.

This article covers where the idea came from, what the evidence says, and how research and retreats handle it. The practical steps for your own session belong in how to prepare, and what to do if things go wrong is in challenging experiences.

Where the idea came from

The definitions researchers still cite come from The Psychedelic Experience, the 1964 book by Timothy Leary, Ralph Metzner and Richard Alpert. (Journal of Psychopharmacology, 2023) A year earlier Leary, with George Litwin and Metzner, had published a paper titled "Reactions to psilocybin administered in a supportive environment". (Journal of Nervous and Mental Disease, 1963)

The practice is older than the phrase. In 1951 the British psychiatrist Humphry Osmond moved to Saskatchewan, Canada, where he spent a decade experimenting with hallucinogens. (Social History of Medicine, 2022) Historians Stephen Lett and Erika Dyck describe Al Hubbard (1901 to 1982), a man with a colourful past in Prohibition-era Seattle who became a skilled session guide, as a central figure in developing the therapeutic setting. (Social History of Medicine, 2022) They quote a handbook by the Saskatchewan researchers Blewett and Chwelos describing Hubbard's method: it "employed a religious setting involving religious themes in pictures and music and a general stressing of the spiritual aspects of the experience". (Social History of Medicine, 2022) Early investigators, they write, consulted architects, music therapists, artists, psychologists and theologians about what kind of room produced the best conditions. (Social History of Medicine, 2022)

Older still are ritual contexts. Research safety guidelines note that indigenous cultures using classic hallucinogens almost always do so in sacramental settings. (Journal of Psychopharmacology, 2008) Brazil's Santo Daime church, studied by the researcher Ido Hartogsohn, shapes ayahuasca sessions with a predetermined order of hymns, symbols and ritual rules. (Frontiers in Pharmacology, 2021) In the United States, federal regulations exempt the nondrug use of peyote in bona fide religious ceremonies of the Native American Church. (eCFR, current) Wild peyote is assessed as Vulnerable, and this site lists no peyote ceremonies; see our peyote position. (IUCN Red List, 2017)

Hartogsohn has argued that set and setting is a close relative of placebo theory, with one difference: it is prescriptive, telling therapists and users how to shape a drug's effects, while placebo theory mainly describes them. (Journal of Psychopharmacology, 2016)

What the research shows

The evidence is more mixed than the slogan.

Dose still comes first. A Zurich analysis pooled 23 controlled studies covering 409 psilocybin administrations to 261 healthy volunteers. (PLOS ONE, 2012) Dose was the most important predictor of every measured response. (PLOS ONE, 2012) Non-drug factors still counted: the personality trait of absorption, an emotionally excitable and active state just before dosing, and few recent psychological problems predicted pleasant and mystical-type experiences. (PLOS ONE, 2012) Being younger, highly emotionally excitable, or dosed in a setting involving a PET brain scan predicted unpleasant or anxious reactions. (PLOS ONE, 2012)

Mindset matters prospectively. An Imperial College team surveyed people who planned to take a psychedelic on their own initiative, before and after, starting with 654 respondents and ending with 212 at the last time point. (Frontiers in Pharmacology, 2018) Clear intentions were linked to mystical-type experiences, and a positive set made a challenging experience less likely. (Frontiers in Pharmacology, 2018) Higher doses and the trait of absorption intensified every kind of experience, good and bad. (Frontiers in Pharmacology, 2018) Wellbeing rose two weeks after the experience and stayed up at four weeks; mystical-type experiences predicted that rise, while challenging experiences did not affect it. (Frontiers in Pharmacology, 2018) The authors conclude that factors outside pharmacology help determine the response. (Frontiers in Pharmacology, 2018) Dropout was heavy and everyone chose to take part, so the results describe motivated users, not everyone.

Supervision and setting show up in harms. In a survey of 1,993 people's worst mushroom trips, risk of physical harm rose with dose and with lack of physical comfort and social support. (Journal of Psychopharmacology, 2016) In the Global Ayahuasca Survey, use in a non-supervised context was linked to physical adverse effects, and use in religious settings to fewer mental health adverse effects. (PLOS Global Public Health, 2022)

Music is part of setting. In interviews with 19 patients given psilocybin for treatment-resistant depression, how they experienced the music predicted reductions in depression a week later, while overall drug intensity did not. (Psychopharmacology, 2018) It is a small study, but it suggests the playlist is not decoration.

The limits of the evidence

Why might psychedelics be so sensitive to context? One proposal, set out in a 2018 opinion piece by the Imperial group, is that the drugs' action at the serotonin 2A receptor and the brain plasticity linked to it make their effects unusually responsive to surroundings. (Journal of Psychopharmacology, 2018) That is a hypothesis, and the authors present it as one to be tested.

Two further cautions. First, much of the research is observational: people who choose a calm, supported setting may differ in other ways from people who do not. Second, set includes expectation, and expectation is hard to separate from the drug. A 2021 review found that psychedelic trials had generally not reported participants' expectations before the trial or how well blinding worked, and argued that effect sizes are probably overestimated as a result. (Expert Review of Clinical Pharmacology, 2021) The influence of set and setting is one reason trial results may not transfer neatly to other contexts.

How clinical trials control setting

Trials treat setting as part of the protocol. The Johns Hopkins safety guidelines describe a living-room-like session room, with comfortable furniture and no visible medical equipment or white coats, because an overly clinical look may increase anxiety. (Journal of Psychopharmacology, 2008) Volunteers often wear eyeshades and listen to music through headphones for most of the session. (Journal of Psychopharmacology, 2008) At least two monitors are present, rapport is built in meetings beforehand, and volunteers with a personal or family history of psychosis are excluded. (Journal of Psychopharmacology, 2008) The Hopkins team even avoided giving volunteers published accounts to read, to keep idiosyncratic expectations out of the room. (Journal of Psychopharmacology, 2008)

Even so, trials have not described their settings consistently. In 2025, 89 experts from 17 countries agreed a reporting standard, the ReSPCT guidelines, listing 30 setting variables across the physical environment, dosing session procedure, therapeutic framework and subjective experience. (Nature Medicine, 2025) The authors note that the field had lacked rigour in reporting these factors. (Nature Medicine, 2025)

How retreats differ from trials

Hartogsohn distinguishes four modalities of set and setting: therapeutic, clinical trial, ritual and recreational, each with different strengths and risks. (Current Topics in Behavioral Neurosciences, 2026) Retreats borrow from several at once and are held to none of their standards by default.

The differences that matter most:

• Screening. Trials exclude people at risk; a 2024 meta-analysis of controlled studies found nine serious adverse events across more than 1,000 administrations, and notes that retreats do not necessarily replicate that screening and monitoring. (Psychiatry Research, 2024)
• Oversight. The Dutch Trimbos Institute warns that nobody checks ceremony quality, including intake, aftercare or the number of sober people present. (DRUGSinfo (Drugs Infolijn), Trimbos-instituut)
• Group size. Trials usually dose one person with two monitors. (Journal of Psychopharmacology, 2008) Group sessions are common elsewhere: Oregon's licensed centres ran 747 group administration sessions in 2025, alongside 4,628 individual ones. (Oregon Health Authority, 2026)
• Law can define the setting. Brazil permits ayahuasca only in religious rituals in places authorised by the user entities, and prohibits selling it. (Ministerio da Justica e Seguranca Publica / Diario Oficial da Uniao, 25 Jan 2010)
• Regulated exceptions. Oregon allows psilocybin only at licensed service centres under a facilitator, after a mandatory screening form that rules out recent lithium use and a history of active psychosis. (Oregon State Legislature, current edition; Oregon Health Authority, Public Health Division, 2026)

Retreat prices and legal status by country are in the Q4 2026 report and retreat countries compared. For what one centre's week looks like, from the ceremonies to the screening, see what a week at Rythmia involves.

What you can check about a setting

You cannot inspect your own mindset from outside, but you can ask about a setting before you book or agree to anything:

• Who screens participants, and do they ask about medicines, heart conditions and psychiatric history? Compare their questions with our screening checklist.
• How many sober staff are present for how many participants, all night?
• Is there a medical professional on site, and how far is the nearest hospital?
• Will anyone be alone with a facilitator, and what is the policy on touch? Chacruna's community guide warns that sessions alone with a healer have been a common context for sexual abuse. (Chacruna Institute for Psychedelic Plant Medicines, 2018)
• Is anything else offered alongside the main substance, such as tobacco purges or toad medicine? Both have been linked to deaths at or after ceremonies. (CBC News, 2015; ICEERS, 2023; Journal of Analytical Toxicology, 2005)
• What happens afterwards, and who can you contact in the following weeks?

Vague or defensive answers are themselves information. The Safety page has the full question list, and the trip-sitting guide covers what good support during a session looks like.